DiaMedica Therapeutics (DMAC) Research & Development (2018 - 2019)
Historic Research & Development for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to $1.8 million.
- DiaMedica Therapeutics' Research & Development rose 2419.02% to $1.8 million in Q4 2019 from the same period last year, while for Dec 2019 it was $7.9 million, marking a year-over-year increase of 7470.15%. This contributed to the annual value of $19.1 million for FY2024, which is 4536.23% up from last year.
- Per DiaMedica Therapeutics' latest filing, its Research & Development stood at $1.8 million for Q4 2019, which was up 2419.02% from $1.6 million recorded in Q3 2019.
- Over the past 5 years, DiaMedica Therapeutics' Research & Development peaked at $2.6 million during Q1 2019, and registered a low of $791000.0 during Q1 2018.